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THE recent demonstration ofan increase in incidence among men in Copenhagen
of papillomnata and carcinomata of the urinary bladder, reported by two of us
(Clemmesen and Nielsen, 1956) and illustrated in Fig. 1, has induced us to compare
as far as possible the figures for this disease from a number of countries. It is
realized by the authors that a real and final comparison of such figures can only
be undertaken through direct collaboration between experts from countries
concerned, so that the present publication will only serve to draw the attention
of such experts to the possibility that the increase observed in Copenhagen may
apply also to other areas.
At present such comparison will have to be limited to mortality rates because
incidence figures are only available for a few countries. Many countries do not
even report specific mortality figures for tumours ofthe bladder, but this difficulty
has been overcome through the courtesy of Dr. Y. Biraud, The Epidemiological
and Statistical Division of World Health Organization, Geneva, who has kindly
placed the basic figures for this study at our disposal.
A more important limitation of our study is that these figures will refer only
to cancer, which exposes them to possible errors in two ways: First, papillomata
will not be included, which lesions, as far as etiology studies are concerned, are
probably as important as the fully developed cancers into which most of them
finally develop. Probably papillomata represent a larger proportion of bladder
tumours in areas where the latter are increasing in frequency than where this is not
the case. Second, it is reasonable to assume that cure is more easy to attain in
cases of papilloma, so that differences between countries in the proportion of
papillomata as well as in the efficiency of therapy may both influence our figures.
On the other hand the Copenhagen figures suggest that an increase may be
observed in cancer cases alone, and in order to give an idea of the interrelation
between morbidity and mortality figures as far as Denmark is concerned, we have
given the age distribution of cases as well as of deaths for all Denmark in Fig. 2
and Table I together with morbidity rates at various ages for men in Copenhagen
for the two subsequent five-year periods concerned. Maybe other areas with
rates similar to those for all Denmark may comprise subdivisions in which an
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increase in cases similar to the increase observed in Copenhagen may appear on
more detailed study, thus facilitating investigations into aetio]ogy.
Fig. 3 to 13 illustrate mortality rates for vesical cancer among men at various
ages per 100,000 inhabitants. The basic figures are given in Table II, and
population figures have been taken from World Health Organization's Annual
Epidemiological and Vital Statistics (1956).
It should be mentioned that differences in age groups beyond 65 should be
taken with some reservation, first because the populations in these age groups are
limited so that relatively few cases may account for the differences, and second
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FIG. 1.-Crude incidence rates per 100,000 for cases of cancer and of papilloma of urinary
bladder, ureter and urethra among women and men in Danish capital, provincial towns and
rural areas from 1943-53.
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because the last point has been determined for the groups aged over 75 as a whole.
We have not deemed it advisable for this orientating study to' make any
calculations of standard error.
1
Fia. 2.-Mortality and morbidity rates at various ages for tumours of urinary bladder
among men in Denmark and Denmark's capital.
.......... Mortality rates for men, Denmark, 1952-53, cancer of bladder and urethra
(W.H.O. Code No. 181).
Morbidity rates for men, Denmark, 1948-52, cancer and papillomata of
bladder, ureter, urethra.
. - -*. Morbidity rates for men, capital, 1943-47, cancer and papillomata of
bladder, ureter, urethra.
-- --. Morbidity rates for men, capital, 1948-52, cancer and papillomata of
bladder, ureter, urethra.
It appears from the diagrams that the age distribution of deaths per 100,000
follows approximately the same course as the Danish curve for the following
countries: Australia, Canada, England and Wales, Italy, Netherlands, Scotland,
TABLE I.-Carcinoma and Papilloma of Urinary Bladder,
Ureter and Urethra
Morbidity rates per 100,000 for men at various ages
A
Age
24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-
Greater
Copenhagen,
1943-47
0.0
2-1
1-0
1-1
2-4
8-0
19-7
20-8
31'1
35.5
69-5
100-5
Greater
Copenhagen,
1948-52
0-0
0-6
1-7
3-2
5-0
15-6
27-1
37-2
64-3
73.6
99-8
126-0
All Denmark,
1948-52
0'0
0.4
0.9
1-1
3-6
8-1
14-5
21 -2
30-1
42-5 57.9 75.7
I
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FIG. 3-13.-Mortality rates at various ages for cancer of urinary bladder and urethra (W.H.O. Code No. 181) among men in various countries. The dotted line represents the curve for Denmark. Fig. 3.-Australia, 1952-53. Fig. 4.-Canada, 1952-53. Fig. 5.- England and Wales, 1952-53. Fig. 6.-Italy, 1952-53. Fig. 7.-Netherlands, 1952-53. Fig. 8.-Scotland, 1952-53. Fig. 9.-U.S.A., 1952-53. Fig. 1O.-Japan, 1952-53. Fig. 11.-New Zealand, 1952-53. Fig. 12.-Norway, 1952-53. Fig. 13.-Sweden, 1952-53.
FIO. 12.
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Men
24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-
Total
Women
24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-
Total
Men
24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-
Total
Women
24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-
Total
Australia,
1952-53.
Deaths
3
2
0
0
5
10
37
33
66
75
82
127
440
0
0
0
2
1
6
8
11
22
22
38
71
181
Italy,
1952-53.
Deaths
11
3
4
16
39
68
135
172
210
232
269
427
1586
2
1
2
6
6
15
38
51
76
108
94
143
542
TABLE IIa
Canada,
1952-53.
Deaths
3
0
5
4
5
18
27
59
90
149
124
281
765
2
1
1
1
3
8
18
12
26
47
55
148
322
TABLE Hb
Japan,
1952-53.
Deaths
3
1
2
1
7
15
21
39
54
79
63
63
348
3
0
3
2
9
8
19
41
49
44
40
45
263
Denmark,
1952-53.
Deaths
0
0
0
0
11
7
17
24
43
48
51
101
302
0
0
0
3
1
3
2
7
15
18
19
44
112
Netherlands,
1952-53.
Deaths
1
0
1
2
4
15
22
43
52
70
89
177
476
England
and Wales,
1952-53.
Deaths
4
1
3
15
37
144
230
334
489
639
695
1123
3714
6
2
4
4
28
51
81
120
153
211
268
615
1543
New Zealand,
1952-53.
Deaths
0
0
0
0
0
3
2
3
7
14
10
19
58
1
0
1
3
4
5
10
11
22
27
31
79
194
0
0
0
0
0
1
2
1
2
1
4
10
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TABLE IIc
Norway, Scotland, Sweden, United States,
1952-53. 1952-53. 1952-53. 1952-53.
Men Deaths Deaths Deaths Deaths
24 . 0 . 2 . 0 . 22
25-29 . 0 . 0 . 0 . 4
30-34 . 0 . 2 . 0 . 8
35-39 . 0 . 2 . 2 . 35
40-44 . 1 . 1 . 3 . 118
45-49 . 1 . 13 . 3 . 248
50-54 . 5 . 23 . 2 . 504
55-59 . 4 . 39 . 17 . 918
60-64 . 7 . 36 . 16 . 1308
65-69 . 7 . 53 . 23 . 1626
70-74 . 15 . 61 . 25 . 1619
75- . 23 . 91 . 49 . 2880
Total . 63 . 323 . 140 . 9290
Women
24 . 0 . 0 . 0 . 6
25-29 . 0 . 0 . 0 . 7
30-34 . 0 . 0 . 0 . 11
35-39 . 0 . 2 . 1 . 47
40-44 . 2 3 . 2 . 71
45-49 . 0 . 7 . 1 . 140
50-54 . 2 . 7 . 4 . 224
55-59 . 3 . 11 . 2 . 306
60-64 . 5 . 18 . 8 . 426
65-69 . 9 . 27 . 9 . 625
70-74 . 4 . 33 . 9 . 766
75- . 27 . 47 . 27 . 1732
Total . 52 . 155 . 63 . 4361
and particularly U.S.A., while on the contrary Japan, New Zealand, Norway and
Sweden show rates considerably lower than the Danish. This seems particularly
striking for Norway and Sweden which in so many ways are similar to Denmark.
SUMMARY
A crude comparison has been made of mortality rates at various ages for
cancer ofthe urinary bladder among men from the following countries: Australia,
Canada, Denmark, England and Wales, Italy, Japan, Netherlands, New Zealand,
Norway, Scotland, Sweden and U.S.A.
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